X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4038) 4038
Book Review (388) 388
Publication (171) 171
Book Chapter (9) 9
Magazine Article (9) 9
Conference Proceeding (4) 4
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3914) 3914
index medicus (3691) 3691
female (3661) 3661
ca-125 antigen - blood (3198) 3198
middle aged (2167) 2167
adult (1935) 1935
aged (1616) 1616
oncology (1395) 1395
biomarkers, tumor - blood (1341) 1341
obstetrics & gynecology (1196) 1196
ovarian neoplasms - blood (1192) 1192
ovarian cancer (1176) 1176
ovarian neoplasms - diagnosis (986) 986
cancer (951) 951
ca-125 (890) 890
ovarian neoplasms - pathology (859) 859
carcinoma (780) 780
ca125 (760) 760
prognosis (741) 741
sensitivity and specificity (707) 707
diagnosis (691) 691
aged, 80 and over (682) 682
neoplasm staging (652) 652
male (578) 578
retrospective studies (562) 562
ca 125 (529) 529
predictive value of tests (490) 490
ovarian neoplasms - surgery (464) 464
diagnosis, differential (427) 427
membrane proteins - blood (401) 401
ovarian neoplasms - drug therapy (382) 382
adolescent (360) 360
women (359) 359
ultrasonography (358) 358
chemotherapy (355) 355
tumors (338) 338
ca-19-9 antigen - blood (333) 333
ovarian neoplasms - diagnostic imaging (321) 321
roc curve (320) 320
prospective studies (318) 318
abridged index medicus (317) 317
biomarkers (317) 317
survival (303) 303
carcinoembryonic antigen - blood (302) 302
treatment outcome (295) 295
ovarian-cancer (293) 293
young adult (293) 293
risk factors (290) 290
research (288) 288
surgery (288) 288
obstetrics and gynecology (276) 276
follow-up studies (262) 262
analysis (260) 260
case-control studies (258) 258
care and treatment (250) 250
expression (244) 244
biomarkers - blood (243) 243
tumor markers (241) 241
risk (238) 238
antigen (226) 226
carcinoembryonic antigen (226) 226
endometriosis (224) 224
ovarian neoplasms - immunology (224) 224
ovarian neoplasms - therapy (224) 224
serum (224) 224
tumor-markers (224) 224
ca-125 antigen - analysis (220) 220
ovarian neoplasms - mortality (214) 214
antigens (206) 206
antigens, tumor-associated, carbohydrate - blood (206) 206
health aspects (206) 206
monoclonal-antibody (206) 206
antineoplastic combined chemotherapy protocols - therapeutic use (202) 202
carcinoma, ovarian epithelial (193) 193
medicine, general & internal (193) 193
hematology, oncology and palliative medicine (185) 185
reproductive biology (182) 182
tomography, x-ray computed (181) 181
ultrasound (181) 181
ca-125 antigen - metabolism (179) 179
endometriosis - blood (179) 179
survival rate (179) 179
benign (178) 178
disease-free survival (178) 178
medicine & public health (177) 177
serum ca-125 (176) 176
management (174) 174
markers (171) 171
neoplasms, glandular and epithelial - blood (171) 171
pregnancy (170) 170
immunohistochemistry (168) 168
enzyme-linked immunosorbent assay (162) 162
time factors (162) 162
recurrence (161) 161
survival analysis (161) 161
cea (157) 157
disease (156) 156
tumor marker (155) 155
antigens, neoplasm - blood (154) 154
reproducibility of results (153) 153
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3711) 3711
Chinese (94) 94
French (58) 58
Polish (47) 47
Spanish (33) 33
Japanese (32) 32
German (25) 25
Italian (15) 15
Russian (14) 14
Bulgarian (6) 6
Czech (5) 5
Danish (4) 4
Hungarian (4) 4
Portuguese (4) 4
Korean (3) 3
Romanian (3) 3
Hebrew (2) 2
Icelandic (2) 2
Turkish (2) 2
Ukrainian (2) 2
Croatian (1) 1
Dutch (1) 1
Finnish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer, ISSN 0008-543X, 11/2014, Volume 120, Issue 21, pp. 3311 - 3319
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2005, Volume 99, Issue 2, pp. 267 - 277
When ovarian carcinoma is diagnosed in stage I, up to 90% of patients can be cured with surgery and currently available chemotherapy. At present, less than 25%... 
HK6 | Claudin 3 | Tumor markers | HK10 | Ovarian carcinoma | CA125 | Osteopontin | FACTOR VEGF | DIAGNOSIS | tumor markers | osteopontin | ovarian carcinoma | SERUM | HUMAN TISSUE KALLIKREINS | OBSTETRICS & GYNECOLOGY | BREAST-CANCER | claudin 3 | ONCOLOGY | GENE-EXPRESSION | PATIENT SURVIVAL | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Epididymal Secretory Proteins - biosynthesis | Immunohistochemistry | Vascular Endothelial Growth Factor A - biosynthesis | Epithelial Cells - metabolism | Kallikreins - biosynthesis | Humans | Membrane Glycoproteins - biosynthesis | Middle Aged | Antigens, Neoplasm - biosynthesis | GPI-Linked Proteins | Ovarian Neoplasms - pathology | beta-Defensins | Sialoglycoproteins - biosynthesis | Antigens - blood | CA-125 Antigen - biosynthesis | CA-19-9 Antigen - biosynthesis | Antigens, Neoplasm - blood | Female | Kallikreins - blood | Ovarian Neoplasms - metabolism | CA-19-9 Antigen - blood | Membrane Proteins - blood | Cystadenoma - metabolism | CA-125 Antigen - blood | Vascular Endothelial Growth Factor A - blood | Membrane Glycoproteins - blood | Ovarian Neoplasms - blood | Sialoglycoproteins - blood | Epithelial Cells - pathology | Glycoproteins - blood | Cystadenoma - blood | Claudin-3 | Mucin-1 | Mucins - blood | Biomarkers, Tumor - blood | Glycoproteins - biosynthesis | Mucins - biosynthesis | Membrane Proteins - biosynthesis | Epididymal Secretory Proteins - metabolism | Antigens - biosynthesis | Neoplasm Staging | Biomarkers, Tumor - biosynthesis | Antigens | Chemotherapy | Oncology, Experimental | Flexible response (Strategy) | Research | Universities and colleges | Deterrence (Strategy) | Cancer | Ovarian cancer | Index Medicus
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 387, Issue 10022, pp. 945 - 956
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 02/2016, Volume 26, Issue 2, pp. 331 - 340
ObjectivesFor patients with endometrial cancer (EC), the screening value of serum human epididymis protein 4 (HE4) remains controversial. We performed... 
Diagnostic test | Endometrial cancer | Serum human epididymis protein 4 | Carbohydrate antigen 125 | Meta-analysis | DIAGNOSTIC-VALUE | ONCOLOGY | HE-4 | CA125 | OVARIAN-CANCER | OBSTETRICS & GYNECOLOGY | Female | Proteins - metabolism | CA-125 Antigen - blood | Membrane Proteins - blood | Endometrial Neoplasms - blood | Humans | Index Medicus
Journal Article
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 2016, Volume 210, pp. 102 - 107
Journal Article
Journal Article